Clinical Trial Update: Pazopanib, Docetaxel, Prednisone Prostate [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pazopanib in combination with docetaxel and prednisone for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Deltasone (prednisone)
• Taxotere (docetaxel)
• Votrient (Pazopanib)

Snippet

Sponsor: Daniel George, MD | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED